These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Methodological and statistical aspects of equivalence and non inferiority trials]. Elie C; De Rycke Y; Jais JP; Marion-Gallois R; Landais P Rev Epidemiol Sante Publique; 2008 Aug; 56(4):267-77. PubMed ID: 18703296 [TBL] [Abstract][Full Text] [Related]
5. Sample sizes for clinical trials with normal data. Julious SA Stat Med; 2004 Jun; 23(12):1921-86. PubMed ID: 15195324 [TBL] [Abstract][Full Text] [Related]
6. Optimum allocation of treatments for Welch's test in equivalence assessment. Dette H; Munk A Biometrics; 1997 Sep; 53(3):1143-50. PubMed ID: 9333344 [TBL] [Abstract][Full Text] [Related]
7. Some issues in the design and interpretation of 'negative' clinical studies. Makuch RW; Johnson MF Arch Intern Med; 1986 May; 146(5):986-9. PubMed ID: 3963987 [TBL] [Abstract][Full Text] [Related]
8. Tests of equivalence and non-inferiority for diagnostic accuracy based on the paired areas under ROC curves. Liu JP; Ma MC; Wu CY; Tai JY Stat Med; 2006 Apr; 25(7):1219-38. PubMed ID: 16158400 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic equivalence: fallacies and falsification. Garrett AD Stat Med; 2003 Mar; 22(5):741-62. PubMed ID: 12587103 [TBL] [Abstract][Full Text] [Related]
11. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials. Daimon T Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944 [TBL] [Abstract][Full Text] [Related]
12. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes. Lui KJ; Chang KC Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514 [TBL] [Abstract][Full Text] [Related]
13. Statistical considerations for noninferiority/equivalence trials in vaccine development. Wang WW; Mehrotra DV; Chan IS; Heyse JF J Biopharm Stat; 2006; 16(4):429-41. PubMed ID: 16892905 [TBL] [Abstract][Full Text] [Related]
14. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes. Hirotsu C Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327 [TBL] [Abstract][Full Text] [Related]
15. Consultants' forum: should post hoc sample size calculations be done? Walters SJ Pharm Stat; 2009; 8(2):163-9. PubMed ID: 18416448 [TBL] [Abstract][Full Text] [Related]
16. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial. Guerra FA; Blatter MM; Greenberg DP; Pichichero M; Noriega FR; Pediatrics; 2009 Jan; 123(1):301-12. PubMed ID: 19117896 [TBL] [Abstract][Full Text] [Related]
18. Health care research: alternative approaches to study design and data analysis. Baghi H Qual Manag Health Care; 2008; 17(4):304-11. PubMed ID: 19020400 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic equivalence: all studies are not created equal. Hatala R; Holbrook A; Goldsmith CH Can J Clin Pharmacol; 1999; 6(1):9-11. PubMed ID: 10465859 [TBL] [Abstract][Full Text] [Related]